- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 249/06 - 1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
Patent holdings for IPC class C07D 249/06
Total number of patents in this class: 629
10-year publication summary
|
53
|
47
|
57
|
43
|
59
|
45
|
46
|
52
|
35
|
10
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
24 |
| Centre National de La Recherche Scientifique | 9632 |
16 |
| Janssen Pharmaceutica N.V. | 3839 |
12 |
| F. Hoffmann-La Roche AG | 7958 |
11 |
| Institut Curie | 531 |
10 |
| Universite de Montpellier | 920 |
10 |
| The Regents of the University of California | 18943 |
9 |
| Bayer Cropscience AG | 2241 |
9 |
| Imago Biosciences, Inc. | 38 |
8 |
| Roche Diagnostics Operations, Inc. | 1375 |
7 |
| Takeda Pharmaceutical Company Limited | 2961 |
7 |
| E. I. du Pont de Nemours and Company | 4345 |
6 |
| Siemens Medical Solutions USA, Inc. | 1584 |
6 |
| FMC Corporation | 910 |
6 |
| The University of Queensland | 666 |
6 |
| Yale University | 2204 |
6 |
| Sigilon Therapeutics, Inc. | 82 |
6 |
| Biogen MA Inc. | 926 |
5 |
| China Pharmaceutical University | 236 |
5 |
| GE Healthcare Limited | 711 |
5 |
| Other owners | 455 |